Position in CYTK
as of Jun 30, 2026
· filed Jul 21, 2026
Position Value
$2,770,208
+$1,722,108 QoQ
Shares Held
32,518
+104.5% QoQ
Ownership
0.023%
of shares outstanding
% of Portfolio
0.17%
of 13F equity value
Holder Rank
#194
of 477 holders
Holding Since
Jun 2024
9 quarters on record
Voting authority
Sole 88%
Shared 0%
None 12%
Common Shares in CYTK Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026OAK RIDGE INVESTMENTS LLC holds $38,931,682 across 19 Biotechnology names. CYTK ranks #7 (7.1% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | AXSM |
Axsome Therapeutics, Inc.
|
14,619 | $3,578,292 | |
| 2 | HALO |
Halozyme Therapeutics, Inc.
|
43,515 | $3,405,919 | |
| 3 | URGN |
UroGen Pharma Ltd.
|
88,591 | $3,260,148 | |
| 4 | CORT |
Corcept Therapeutics Inc
|
34,172 | $2,971,255 | |
| 5 | TVTX |
Travere Therapeutics, Inc.
|
52,234 | $2,967,413 | |
| 6 | BBIO |
BridgeBio Pharma, Inc.
|
38,190 | $2,844,391 | |
| 7 | CYTK |
Cytokinetics Inc
This page
|
32,518 | $2,770,208 | |
| 8 | MIRM |
Mirum Pharmaceuticals, Inc.
|
22,408 | $2,623,304 |
All Filings in CYTK
Export CSV
9 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $2,770,208 | 32,518 | Shares | Sole | 2026-07-21 | |
| 2026-03-31 | $1,048,100 | 15,902 | Shares | Sole | 2026-04-30 | |
| 2025-12-31 | $996,116 | 15,677 | Shares | Sole | 2026-01-23 | |
| 2025-09-30 | $882,987 | 16,066 | Shares | Sole | 2025-10-29 | |
| 2025-06-30 | $536,933 | 16,251 | Shares | Sole | 2025-07-25 | |
| 2025-03-31 | $687,088 | 17,096 | Shares | Sole | 2025-05-13 | |
| 2024-12-31 | $699,202 | 14,864 | Shares | Sole | 2025-01-15 | |
| 2024-09-30 | $938,308 | 17,771 | Shares | Sole | 2024-10-28 | |
| 2024-06-30 | $1,001,679 | 18,488 | Shares | Sole | 2024-10-28 | |
| No filing history on record for this holder in this stock. | ||||||